Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
0.8800
+0.0990 (12.68%)
At close: Aug 22, 2025, 4:00 PM
0.8500
-0.0300 (-3.41%)
After-hours: Aug 22, 2025, 4:00 PM EDT
Dyadic International Market Cap
Dyadic International has a market cap or net worth of $30.76 million as of August 22, 2025. Its market cap has decreased by -22.13% in one year.
Market Cap
30.76M
Enterprise Value
30.84M
1-Year Change
-22.13%
Ranking
Category
Stock Price
$0.88
Market Cap Chart
Since April 18, 2019, Dyadic International's market cap has decreased from $94.80M to $30.76M, a decrease of -67.55%. That is a compound annual growth rate of -16.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 30.80M | -40.54% |
| Dec 31, 2024 | 51.80M | 11.64% |
| Dec 29, 2023 | 46.40M | 32.19% |
| Dec 30, 2022 | 35.10M | -72.34% |
| Dec 31, 2021 | 126.90M | -14.20% |
| Dec 31, 2020 | 147.90M | 4.89% |
| Dec 31, 2019 | 141.00M | 48.73% |
| Apr 18, 2019 | 94.80M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 637.23B |
| Johnson & Johnson | 430.92B |
| AbbVie | 370.09B |
| UnitedHealth Group | 274.74B |
| AstraZeneca | 250.88B |
| Novartis AG | 246.51B |
| Novo Nordisk | 246.31B |
| Abbott Laboratories | 229.74B |